At Aerin Medical, our mission is to provide ENTs with advanced treatment options for chronic nasal conditions that positively affect the quality of life of millions of patients. We believe that patients deserve the freedom to breathe better and live better, so that they can get back to living the life they love.
Aerin Medical offers ENT physicians a portfolio of non-invasive, office friendly products to fill the unmet needs of people suffering from chronic nasal airway conditions. The company’s first products, VivAer® for treating nasal airway obstruction and RhinAer® for treating chronic rhinitis, are FDA-cleared and commercially available in the United States. Both products enable ENT physicians to effectively and comprehensively treat nasal airway conditions under local anesthesia with minimal to no downtime for patients. VivAer and RhinAer use Aerin Medical’s proprietary, temperature-controlled radiofrequency (RF) technology. Unlike traditional RF treatments, the Aerin System automatically adjusts power output to maintain target temperature for therapeutic benefit while sparing surrounding tissue, including mucosa. Both VivAer and RhinAer fit seamlessly into the office or operating room.
Our company shares news releases to keep our various stakeholders informed and engaged in our recent activities. To learn more, please see our News & Media page for the latest press announcements, VivAer® and RhinAer® in the media, and physician spotlight interviews.
Winner of the 2021 MedTech Breakthrough Award for Best New Therapeutic Solution.
